RGn550
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RGn550, covering 2024-12-05 to 2024-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Clinical Investigation Evaluating the Safety and Performance of RGn550 in Treating Sportspeople Suffering From Acute Concussion Syndrome [NA]